Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Operating Leases: 2019-2024

  • CureVac N.V's Operating Leases fell 7.47% to $41.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $41.6 million, marking a year-over-year decrease of 7.47%. This contributed to the annual value of $41.6 million for FY2024, which is 7.47% down from last year.
  • As of Q4 2024, CureVac N.V's Operating Leases stood at $41.6 million, which was down 7.47% from $45.0 million recorded in Q4 2023.
  • In the past 5 years, CureVac N.V's Operating Leases ranged from a high of $45.0 million in Q4 2023 and a low of $33.1 million during Q4 2021.
  • Its 3-year average for Operating Leases is $43.2 million, with a median of $42.9 million in 2022.
  • In the last 5 years, CureVac N.V's Operating Leases surged by 129.36% in 2020 and then decreased by 7.86% in 2021.
  • CureVac N.V's Operating Leases (Quarterly) stood at $35.9 million in 2020, then fell by 7.86% to $33.1 million in 2021, then increased by 29.91% to $42.9 million in 2022, then rose by 4.80% to $45.0 million in 2023, then decreased by 7.47% to $41.6 million in 2024.
  • Its last three reported values are $41.6 million in Q4 2024, $45.0 million for Q4 2023, and $42.9 million during Q4 2022.